269
Views
1
CrossRef citations to date
0
Altmetric
Original Research

The Association Between Depressive Symptoms and Sarcopenia Among Community-Dwelling Older Adults: A Cross-Sectional Study

ORCID Icon, ORCID Icon, ORCID Icon, &
Pages 837-846 | Published online: 22 Apr 2022

References

  • Williams SN, Armitage CJ, Tampe T, Dienes K. Public perceptions and experiences of social distancing and social isolation during the COVID-19 pandemic: a UK-based focus group study. BMJ open. 2020;10(7):e039334. doi:10.1136/bmjopen-2020-039334
  • Setiawati Y, Wahyuhadi J, Joestandari F, Maramis MM, Atika A. Anxiety and resilience of healthcare workers during COVID-19 pandemic in Indonesia. J Multidiscip Healthc. 2021;14:1. doi:10.2147/JMDH.S276655
  • Ali AM, Kunugi H. Screening for sarcopenia (physical frailty) in the COVID-19 era. Int J Endocrinol. 2021;2021:8738. doi:10.1155/2021/5563960
  • Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age and Ageing. 2019;48(1):16–31. doi:10.1093/ageing/afy169
  • Cruz-Jentoft AJ, Sayer AA. Sarcopenia. Lancet. 2019;393(10191):2636–2646. doi:10.1016/S0140-6736(19)31138-9
  • Tian S, Xu Y, Han F. Prevalence of sarcopenia in the community-dwelling, elderly Chinese population: a systematic review and meta-analysis. Lancet. 2017;390:S35. doi:10.1016/S0140-6736(17)33173-2
  • Ali AM, Kunugi H. Physical frailty/sarcopenia as a key predisposing factor to coronavirus disease 2019 (COVID-19) and its complications in older adults. BioMed. 2021;1(1):11–40. doi:10.3390/biomed1010002
  • Ali AM, Kunugi H. Skeletal muscle damage in COVID-19: a call for action. Medicina. 2021;57(4):372. doi:10.3390/medicina57040372
  • Ali AM, Kunugi H. Apitherapy for age-related skeletal muscle dysfunction (sarcopenia): a review on the effects of royal jelly, propolis, and bee pollen. Foods. 2020;9(10):1362. doi:10.3390/foods9101362
  • Chen X, Guo J, Han P, et al. Twelve-Month Incidence of Depressive Symptoms in Suburb-Dwelling Chinese Older Adults: role of Sarcopenia. J Am Med Dir Assoc. 2019;20(1):64–69. doi:10.1016/j.jamda.2018.07.017
  • Beaudart C, Reginster JY, Petermans J, et al. Quality of life and physical components linked to sarcopenia: the SarcoPhAge study. Exp Gerontol. 2015;69:103–110. doi:10.1016/j.exger.2015.05.003
  • Goates S, Du K, Arensberg M, Gaillard T, Guralnik J, Pereira SL. Economic impact of hospitalizations in US adults with sarcopenia. J Frailty Aging. 2019;8(2):93–99. doi:10.14283/jfa.2019.10
  • Wang PY, Li Y, Wang Q. Sarcopenia: an underlying treatment target during the COVID-19 pandemic. Nutrition. 2021;84:111104. doi:10.1016/j.nut.2020.111104
  • Lim WS, Liang CK, Assantachai P, et al. COVID‐19 and older people in Asia: asian Working Group for Sarcopenia calls to action. Geriatr Gerontol Int. 2020;20(6):547–558. doi:10.1111/ggi.13939
  • Chen WJ, Assantachai P, et al. Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020;21(3):300–307. doi:10.1016/j.jamda.2019.12.012
  • Liu X, Hou L, Zhao W, et al. The Comparison of Sarcopenia Diagnostic Criteria using AWGS 2019 with the Other Five Criteria in West China. Gerontology. 2021;67(3):290–300. doi:10.1159/000513247
  • Huang J, He F, Gu X, Chen S, Tong Z, Zhong S. Estimation of sarcopenia prevalence in individuals at different ages from Zheijiang province in China. Aging. 2021;13(4):6066. doi:10.18632/aging.202567
  • Assariparambil AR, Noronha JA, Kamath A, et al. Depression among older adults: a systematic review of South Asian countries. Psychogeriatrics. 2021;21(2):201–219. doi:10.1111/psyg.12644
  • Radovanović S, Kocić S, Sekulić M, Ristić G, Radević S, Janićijević K. Prevalence of depression over 65 in Serbia-public health significance. Vojnosanitetski pregled. 2020;1:132. doi:10.2298/VSP1912260132R
  • Casey DA. Depression in older adults: a treatable medical condition. Primary Care. 2017;44(3):499–510. doi:10.1016/j.pop.2017.04.007
  • Ali AM, Ali EM, Abou Mousa A, Ahmed ME, Hendawy AO. Bee honey and exercise for improving physical performance, reducing fatigue, and promoting an active lifestyle during COVID-19. Sports Med Health Sci. 2021;3(3):177–180. doi:10.1016/j.smhs.2021.06.002
  • Ali AM, Alkhamees AA, Hori H, Kim Y, Kunugi H. The Depression Anxiety Stress Scale 21: development and Validation of the Depression Anxiety Stress Scale 8-Item in Psychiatric Patients and the General Public for Easier Mental Health Measurement in a Post COVID-19 World. Int J Environ Res Public Health. 2021;18(19):10142. doi:10.3390/ijerph181910142
  • Szlejf C, Suemoto CK, Brunoni AR, et al. Depression is associated with sarcopenia due to low muscle strength: results from the ELSA-Brasil study. J Am Med Dir Assoc. 2019;20(12):1641–1646. doi:10.1016/j.jamda.2018.09.020
  • Chen GJ, Han P, et al. Twelve-month incidence of depressive symptoms in suburb-dwelling Chinese older adults: role of sarcopenia. J Am Med Dir Assoc. 2019;20(1):64–69. doi:10.1016/j.jamda.2018.07.017
  • Byeon CH, Kang KY, Kang SH, Kim HK, Bae EJ. Sarcopenia Is Not Associated with Depression in Korean Adults: results from the 2010-2011 Korean National Health and Nutrition Examination Survey. Korean J Fam Med. 2016;37(1):37–43. doi:10.4082/kjfm.2016.37.1.37
  • Nipp RD, Fuchs G, El‐Jawahri A, et al. Sarcopenia is associated with quality of life and depression in patients with advanced cancer. The oncologist. 2018;23(1):97. doi:10.1634/theoncologist.2017-0255
  • Kim KHS, Eun CR, et al. Depression Is Associated with Sarcopenia, Not Central Obesity, in Elderly K orean Men. J Am Geriatr Soc. 2011;59(11):2062–2068. doi:10.1111/j.1532-5415.2011.03664.x
  • Byeon C-H, Kang K-Y, Kang S-H, Kim H-K, Bae E-J. Sarcopenia is not associated with depression in Korean adults: results from the 2010–2011 Korean National Health and Nutrition Examination Survey. Korean J Fam Med. 2016;37(1):37. doi:10.4082/kjfm.2016.37.1.37
  • Ishii S, Chang C, Tanaka T, et al. The association between sarcopenic obesity and depressive symptoms in older Japanese adults. PLoS One. 2016;11:9. doi:10.1371/journal.pone.0162898
  • Faul F, Erdfelder E, Lang AG, Buchner A. G* Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39(2):175–191. doi:10.3758/BF03193146
  • Faul F, Erdfelder E, Buchner A, Lang A-G. Statistical power analyses using G* Power 3.1: tests for correlation and regression analyses. Behav Res Methods. 2009;41(4):1149–1160. doi:10.3758/BRM.41.4.1149
  • Washburn R, Smith K, Jette A, Janney C. Physical Activity Scale for the Elderly: Administration and Scoring Instruction Manual. Watertown: New England Research Institute; 1991.
  • Vaughan K, Miller WC. Validity and reliability of the Chinese translation of the Physical Activity Scale for the Elderly (PASE). Disabil Rehabil. 2013;35(3):191–197. doi:10.3109/09638288.2012.690498
  • Curcio F, Liguori I, Cellulare M, et al. Physical activity scale for the elderly (PASE) score is related to sarcopenia in noninstitutionalized older adults. J Geriatric Physical Therapy. 2019;42(3):130–135. doi:10.1519/JPT.0000000000000139
  • World Health Organization. Regional Office for the Western P. The Asia-Pacific Perspective: Redefining Obesity and Its Treatment. Sydney: Health Communications Australia; 2000. Available from: http://iris.wpro.who.int/handle/10665.1/5379. Accessed March 26, 2022.
  • Chen WJ, Assantachai P. Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Med Res. 2020;21(3):300–307. e2. doi:10.1016/j.jamda.2019.12.012
  • Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. 1982;17(1):37–49. doi:10.1016/0022-3956(82)90033-4
  • Chan AC-M. Clinical validation of the geriatric depression scale (GDS) Chinese version. J Aging Health. 1996;8(2):238–253. doi:10.1177/089826439600800205
  • Jongenelis K, Pot A, Eisses A, et al. Diagnostic accuracy of the original 30‐item and shortened versions of the Geriatric Depression Scale in Nursing home patients. Int J Geriatric Psychiatry. 2005;20(11):1067–1074. doi:10.1002/gps.1398
  • Mo Y-H, Zhong J, Dong X, et al. Comparison of three screening methods for sarcopenia in community-dwelling older persons. J Am Med Dir Assoc. 2020;22(4):746–750.e1. doi:10.1016/j.jamda.2020.05.041
  • Chen HL, Zhang Y, Dong B. Analysis of the Prevalence of Sarcopenia and Its Risk Factors in the Elderly in the Chengdu Community. J Nutr Health Aging. 2021;25(5):600–605. doi:10.1007/s12603-020-1559-1
  • Lee R, Liu LK, Peng LN, Lin MH, Chen LK. Comparisons of sarcopenia defined by IWGS and EWGSOP criteria among older people: results from the I-Lan longitudinal aging study. J Am Med Dir Assoc. 2013;14(7):528.e1–528. e7. doi:10.1016/j.jamda.2013.03.019
  • Pang BWJ, Wee S-L, Lau LK, et al. Prevalence and associated factors of Sarcopenia in Singaporean adults—the Yishun Study. J Am Med Dir Assoc. 2021;22(4):885.e1–885. e10. doi:10.1016/j.jamda.2020.05.029
  • Wang H, Hai S, Liu Y, et al. Association between depressive symptoms and sarcopenia in older Chinese community-dwelling individuals. Clin Interv Aging. 2018;13:1605. doi:10.2147/CIA.S173146
  • Heok KE, Ho R. The many faces of geriatric depression. Curr Opin Psychiatry. 2008;21(6):540–545. doi:10.1097/YCO.0b013e328311cdae
  • Cheruvu VK, Chiyaka ET. Prevalence of depressive symptoms among older adults who reported medical cost as a barrier to seeking health care: findings from a nationally representative sample. BMC Geriatr. 2019;19(1):1–10. doi:10.1186/s12877-019-1203-2
  • Robb CE, de Jager CA, Ahmadi-Abhari S, et al. Associations of social isolation with anxiety and depression during the early COVID-19 pandemic: a survey of older adults in London, UK. Front Psychiatry. 2020;11:11. doi:10.3389/fpsyt.2020.00011
  • Marino FR, Lessard DM, Saczynski JS, et al. Gait speed and mood, cognition, and quality of life in older adults with atrial fibrillation. J Am Heart Assoc. 2019;8(22):e013212. doi:10.1161/JAHA.119.013212
  • Sanders JB, Bremmer MA, Comijs HC, Deeg DJ, Beekman AT. Gait speed and the natural course of depressive symptoms in late life; an independent association with chronicity? J Am Med Dir Assoc. 2016;17(4):331–335. doi:10.1016/j.jamda.2015.11.016
  • Veronese N, Stubbs B, Trevisan C, et al. Poor physical performance predicts future onset of depression in elderly people: progetto Veneto Anziani Longitudinal Study. Phys Ther. 2017;97(6):659–668. doi:10.1093/ptj/pzx017
  • Briggs R, Carey D, Claffey P, et al. Do differences in spatiotemporal gait parameters predict the risk of developing depression in later life? J Am Geriatr Soc. 2019;67(5):1050–1056. doi:10.1111/jgs.15783
  • Chen L, Sheng Y, Qi H, Tang T, Yu J, Lv S. Correlation of sarcopenia and depressive mood in older community dwellers: a cross-sectional observational study in China. BMJ open. 2020;10(9):e038089. doi:10.1136/bmjopen-2020-038089
  • Sanders JB, Bremmer MA, Deeg DJ, Beekman AT. Do depressive symptoms and gait speed impairment predict each other’s incidence? A 16‐year prospective study in the community. J Am Geriatr Soc. 2012;60(9):1673–1680. doi:10.1111/j.1532-5415.2012.04114.x
  • Chen L-K, Woo J, Assantachai P, et al. Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020;21(3):300–307. doi:10.1016/j.jamda.2019.12.012
  • Yazar HO, Yazar T. Prevalence of sarcopenia in patients with geriatric depression diagnosis. Ir J Med Sci. 2019;188(3):931–938. doi:10.1007/s11845-018-01957-7
  • Chen X, Guo J, Han P, et al. Twelve-month incidence of depressive symptoms in suburb-dwelling Chinese older adults: role of sarcopenia. J Am Med Dir Assoc. 2019;20(1):64–69. doi:10.1016/j.jamda.2018.07.017
  • Gómez-Tabares G, García W, Bedoya-Dorado E, Cantor EJC. Screening sarcopenia through SARC-F in postmenopausal women: a single-center study from South America. Climacteric. 2019;22(6):627–631. doi:10.1080/13697137.2019.1631788
  • Kao T-W, Peng T-C, Chen W-L, Han D-S, Chen C-L, Yang W-SJA. Impact of adiposity on muscle function and clinical events among elders with dynapenia. Aging (Albany NY). 2021;13(5):7247. doi:10.18632/aging.202581
  • Buckinx F, Reginster J-Y, Dardenne N, et al. Concordance between muscle mass assessed by bioelectrical impedance analysis and by dual energy X-ray absorptiometry: a cross-sectional study. BMC Musculoskelet Disord. 2015;16(1):1–7. doi:10.1186/s12891-015-0510-9
  • Zambone MA, Liberman S, Garcia MLB. Anthropometry, bioimpedance and densitometry: comparative methods for lean mass body analysis in elderly outpatients from a tertiary hospital. Exp Gerontol. 2020;138:111020. doi:10.1016/j.exger.2020.111020